List of Bach Pharma patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9358225 Method for treating neurodegeneration using a p38MAPK inhibitor	Patent 9358225 was granted and assigned to Bach Pharma on June, 2016 by the United States Patent and Trademark Office.	Bach Pharma	Bach Pharma	United States Patent and Trademark Office	9358225	June 7, 2016
‌ US Patent 9968602 Modulation of cell fates and activities by phthalazinediones	Patent 9968602 was granted and assigned to Bach Pharma on May, 2018 by the United States Patent and Trademark Office.	Bach Pharma	Bach Pharma	United States Patent and Trademark Office	9968602	May 15, 2018
‌ US Patent 7691819 Modulation of cell fates and activities by phthalazinediones	Patent 7691819 was granted and assigned to Bach Pharma on April, 2010 by the United States Patent and Trademark Office.		Bach Pharma	United States Patent and Trademark Office	7691819	April 6, 2010
‌ US Patent 9732043 Process for preparing 5-amino-2,3-dihydrophthalazine-1,4-dione monosodium salt	Patent 9732043 was granted and assigned to Bach Pharma on August, 2017 by the United States Patent and Trademark Office.	Bach Pharma	Bach Pharma	United States Patent and Trademark Office	9732043	August 15, 2017
‌ US Patent 8895555 Methods of treating intestinal diseases and inflammatory conditions related to HIV-AIDS	Patent 8895555 was granted and assigned to Bach Pharma on November, 2014 by the United States Patent and Trademark Office.		Bach Pharma	United States Patent and Trademark Office	8895555	November 25, 2014
‌ US Patent 7326690 Modulation of cell fates and activities by phthalazinediones	Patent 7326690 was granted and assigned to Bach Pharma on February, 2008 by the United States Patent and Trademark Office.		Bach Pharma	United States Patent and Trademark Office	7326690	February 5, 2008
‌ US Patent 6953799 Modulation of cell fates and activities by diketo phthalazines	Patent 6953799 was granted and assigned to Bach Pharma on October, 2005 by the United States Patent and Trademark Office.		Bach Pharma	United States Patent and Trademark Office	6953799	October 11, 2005